Sunday, December 06, 2020 3:01:21 PM
Going after several key market segments with POWERFUL all natural, non-toxic treatments (monoclonal antibodies, immune system boosters/modulators).
Some treatments will be over the counter, while others will require RX. Looks like they're going for "severe, late stage" coronavirus cases with their monoclonal antibodies. Big pharma will want in on that.
Wholly owned patent licensing subsidiaries formed to do business with the HIGHEST BIDDER.
Big pharma biding war very real possibility.
Keep getting the word out on Twitter, Stocktwits and iHub.
I don't think $ENZC will be in the OTC for very much longer. 1 or 2 licensing deals with Big pharma can get you called up to Nasdaq in no time.
https://twitter.com/UncleBillyMoney/status/1335673721961365504?s=20
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM